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o r i g i n a l a r t i c l e
Does Colonization with Methicillin-Susceptible Staphylococcus
aureus Protect against Nosocomial Acquisition of
Methicillin-Resistant S. aureus ?
Caroline Landelle, PharmD, PhD;1,a Anne Iten, MD;1,2,a Ilker Uc¸kay, MD;1 Hugo Sax, MD;1 Ve´ronique Camus, RN;1
Gilles Cohen, PhD;3 Gesuele Renzi, BSc;4 Jacques Schrenzel, MD;4 Didier Pittet, MD, MS;1
Arnaud Perrier, MD;2 Stephan Harbarth, MD, MS1
objective. To test the hypothesis that methicillin-susceptible Staphylococcus aureus (MSSA) carriage may protect against nosocomial
methicillin-resistant S. aureus (MRSA) acquisition by competing for colonization of the anterior nares.
design. Prospective cohort and nested case-control study.
setting. Swiss university hospital.
patients. All adult patients admitted to 14 wards of the general medicine division between April 1 and October 31, 2007.
methods. Patients were screened for MRSA and MSSA carriage at admission to and discharge from the division. Associations between
nosocomial MRSA acquisition and MSSA colonization at admission and other confounders were analyzed by univariable and multivariable
analysis.
results. Of 898 patients included, 183 (20%) were treated with antibiotics. Nosocomial MRSA acquisition occurred in 70 (8%) of the
patients (case patients); 828 (92%) of the patients (control subjects) were free of MRSA colonization at discharge. MSSA carriage at
admission was 20% and 21% for case patients and control subjects, respectively. After adjustment by multivariate logistic regression, no
association was observed between MSSA colonization at admission and nosocomial MRSA acquisition (adjusted odds ratio [aOR], 1.2
[95% confidence interval (CI), 0.6–2.3]). By contrast, 4 independent predictors of nosocomial MRSA acquisition were identified: older age
(aOR per 1-year increment, 1.05 [95% CI, 1.02–1.08]); increased length of stay (aOR per 1-day increment, 1.05 [95% CI, 1.02–1.09]);
increased nursing workload index (aOR per 1-point increment, 1.02 [95% CI, 1.01–1.04]); and previous treatment with macrolides (aOR,
5.6 [95% CI, 1.8–17.7]).
conclusions. Endogenous MSSA colonization does not appear to protect against nosocomial MRSA acquisition in a population of
medical patients without frequent antibiotic exposure.
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Risk factors and colonization patterns differ between meth-
icillin-resistant Staphylococcus aureus (MRSA) and methicil-
lin-susceptible S. aureus (MSSA). The prevalence of MSSA
carriage at hospital admission varies between 15% and 25%,
similar to carriage in the community.1-3 The admission prev-
alence of MRSA carriage in settings with endemic MRSA can
vary substantially and is reported to range from 3% to
15%.4-7
Patients who acquire MRSA incur significant risks of sub-
sequent infection.8-10 Importantly, MRSA carriage is associ-
ated with a fourfold increased infection risk compared with
MSSA colonization.11,12 Many studies have evaluated the risk
factors for nosocomial MRSA acquisition (eg, comorbidities,
exogenous factors, and antimicrobial exposure) to improve
preventive measures,13-15 but despite 50 years of research, less
is known about the protective factors at the host level. It has
been hypothesized that endogenous MSSA carriage may pro-
tect against exogenous MRSA acquisition by competing for
colonization of the anterior nares.16 In a retrospective case-
control study, Huang and colleagues observed that MSSA
carriage reduced the odds of MRSA acquisition by 50% in
critically ill patients, after controlling for other risk factors.17
This content downloaded from 130.60.47.58 on Tue, 16 Dec 2014 10:59:01 AM
All use subject to JSTOR Terms and Conditions
528 infection control and hospital epidemiology may 2014, vol. 35, no. 5
By contrast, a small retrospective study suggested that carriage
of MSSA was not protective against MRSA acquisition.18 Of
note, both studies evaluated MRSA in the nares only.
The aim of this study was to test the hypothesis that en-
dogenous MSSA colonization detected in the nares and groin
may reduce the risk of exogenous, nosocomial MRSA ac-
quisition. Our secondary objectives were to determine the
MRSA acquisition rate and the prevalence of MSSA at ad-
mission and discharge.
methods
Study Setting
We conducted a prospective, nested case-control study at the
University of Geneva Hospital, Geneva, Switzerland, in a co-
hort of patients admitted to 14 wards of the general internal
medicine division between April 1 and October 31, 2007. The
admission prevalence of MRSA among hospitalized patients
in this department was 2.9% in 2003 and 2.4% in 2010.4,19
Nares and groin samples were collected from patients at ad-
mission and discharge to detect MRSA and MSSA carriage.
Hand hygiene was performed according to the World Health
Organization “My 5 moments for hand hygiene” concept,20
with a compliance of 66.3% (447 of 674) among healthcare
workers during the study period. Contact precautions were
applied to previously known MRSA carriers in case of re-
admission and were implemented as soon as a newly dis-
covered case of MRSA carriage was notified via an automatic
laboratory alert system.21 The institutional review board ap-
proved the study as a continuous quality improvement project
for improved MRSA control; therefore, no informed consent
was required.
Study Design
We included patients older than 18 years of age who were
hospitalized for more than 48 hours with a negative screening
culture (nares and groin) for MRSA obtained at admission.
Exclusion criteria were MRSA colonization or infection at
admission, an interval less than 48 hours between admission
and MRSA discharge screening, and lack of admission and/
or discharge data on MRSA screening. Case patients were
defined as subjects who had at least 1 subsequent MRSA-
positive nares and groin screening culture at discharge or a
MRSA-positive clinical culture; control subjects had all sub-
sequent screening swab samples and clinical cultures without
MRSA.
Microbiologic Methods
Two nares and 2 groin S. aureus screening specimens from
individual patients were pooled in the laboratory and inoc-
ulated directly onto SAURid and MRSAid plates (bio-
Me´rieux). Pooled swab samples were then inoculated into a
colistin salt (CS) broth. When no MRSA was detected on
chromogenic agar at day 1, a second SAURid plate and a
second MRSAid plate were inoculated after overnight en-
richment in the CS broth. Identification of MSSA and MRSA
from colonies suggestive of staphylococci were performed
using standard methods4 according to Clinical and Laboratory
Standards Institute recommendations and confirmed with
multiplex quantitative polymerase chain reaction (PCR) for
the genes femA and mecA.22
Data Collection
We collected demographic and clinical information prospec-
tively. Additional data were obtained by retrospectively ac-
cessing electronic medical records. Nursing workload was
evaluated by the Projet de Recherche en Nursing (PRN) in-
dex.23 This index includes 8 categories of nursing procedures
covering all technical, relational, and basic tasks. PRN items
are scored routinely by the nurse in charge of each patient.
The time-based work load for each patient is then calculated
daily. Patient comorbidities were recorded according to the
updated Charlson comorbidity index.24 We also recorded an-
tibiotic use by accessing individual inpatient prescription
data, as previously described.25
Statistical Analysis
Baseline characteristics were described by frequencies, me-
dians, and interquartile ranges (IQRs). Groups were com-
pared by means of the Mann-Whitney U test, Pearson x2 test,
or Fisher exact test as appropriate for continuous and cate-
gorical variables. The main exposure of interest was MSSA
colonization status at admission, and the primary outcome
was nosocomial MRSA acquisition by patients initially free
of MRSA. Variables potentially associated with nosocomial
MRSA acquisition were tested using univariate analysis. Var-
iables with a P value of less than or equal to .2 in univariable
analysis were candidates for multivariable analysis, as was the
main exposure of interest (MSSA colonization status at ad-
mission). Nonnormally distributed continuous variables were
transformed into categorical variables on the basis of median
values. Multivariable modeling was performed by using lo-
gistic regression analysis to calculate adjusted odds ratios
(aORs) and 95% confidence intervals (CIs). Interactions be-
tween the main exposure of interest and variables potentially
associated with nosocomial MRSA acquisition were tested to
assess effect modification. All statistical tests were 2-tailed,
and a P value less than or equal to .05 was considered to be
statistically significant. We used PASW, version 18 (SPSS), for
all analyses.
results
A total of 1,857 patients were admitted to the division during
the study period. Nine hundred fifty-nine were excluded from
additional analysis for the following reasons: 103 (5.5%) were
known MRSA carriers at hospital admission, and 228 (12.3%)
had a length of stay less than 48 hours. For 628 (33.8%) of
the patients, screening was not performed either at admission
This content downloaded from 130.60.47.58 on Tue, 16 Dec 2014 10:59:01 AM
All use subject to JSTOR Terms and Conditions
mssa vs mrsa colonization 529
figure 1. Study flow chart of patient inclusion and results of patient screening. MRSA, methicillin-resistant Staphylococcus aureus; MSSA,
methicillin-susceptible S. aureus.
or discharge. Finally, 898 (48.4%) of the patients were in-
cluded in the analysis (Figure 1).
Comparison between the 628 patients with missing screen-
ing data and the 898 patients with complete admission and
discharge screening showed no difference for sex, length of
stay (LOS), and previous antibiotic use. Patients with missed
screening were younger, had a lower nursing workload index,
and were more likely to have a malignancy than patients with
complete screening.
Among the 898 patients who met the study inclusion cri-
teria, 526 (58.6%) were men; median LOS was 8 days. One
hundred ninety-two (21.4%) were MSSA carriers at admis-
sion, and 183 (20.4%) were treated with antibiotics (Table
1). Seventy (7.8%) of the patients (case patients) acquired
nosocomial MRSA, including 3 symptomatic infections. Eight
hundred twenty-eight (92.2%) of the patients (control sub-
jects) were discharged from the division free of MRSA col-
onization (Figure 1). Characteristics of case patients and con-
trol subjects are shown in Table 1.
The effect of MSSA carriage at admission on the risk of
nosocomial MRSA acquisition was first examined by uni-
variate analysis and showed that the rates were almost iden-
tical in both groups: 14 nosocomial MRSA acquisitions
(7.3%) were recorded among 192 MSSA carriers, compared
with 56 nosocomial MRSA acquisitions (7.9%) among 706
MSSA-negative patients at admission (crude OR, 0.91 [95%
CI, 0.50–1.68]). By contrast, 6 variables were found to be
associated with an increased risk of nosocomial MRSA ac-
quisition by univariate analysis (P ! .01): age, LOS, number
of comorbidities, nursing workload, ward allocation, and
macrolide use (Table 1). No difference was observed for
MSSA carriage between case patients and control subjects at
discharge.
By multivariate regression analysis, 4 independent predic-
tors of nosocomial MRSA acquisition were identified: older
age (aOR per 1-year increment, 1.05 [95% CI, 1.02–1.08]),
increased LOS (aOR per 1-day increment, 1.05 [95% CI,
1.02–1.09]), increased nursing workload index (aOR per 1-
point increment, 1.02 [95% CI, 1.01–1.04]), and previous
treatment with macrolides (aOR, 5.6 [95% CI, 1.77–17.73]).
After adjustment for the above-mentioned independent risk
factors, no association was observed between MSSA coloni-
zation at admission and nosocomial MRSA acquisition (aOR,
1.17 [95% CI, 0.60–2.30]). Age, sex, and the Charlson co-
morbidity index had no effect modification on the MSSA
colonization status at admission.
Among 192 MSSA carriers identified at admission, 85
(44.3%) of the patients were still MSSA positive at discharge
from the division, and 107 (55.7%) were MSSA negative after
hospital stay (Figure 1). Among 706 patients without MSSA
carriage at admission, 28 (4%) of the patients were MSSA
positive after hospital stay. Of the 70 case patients with nos-
ocomial MRSA acquisition, 14 were MSSA positive at ad-
mission. At discharge from the division, 8 became MSSA
negative; none of the 56 MSSA-free patients at admission
became MSSA positive.
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table 1. Characteristics of Case Patients with and Control Subjects without Nosocomial Methicillin-Resistant Staphylococcus
aureus (MRSA) Acquisition by Univariable Analysis
Variable
Total
(n p 898)
Case patients
(n p 70)
Control subjects
(n p 828) P
Age, median (IQR), years 68.8 (56.0–79.3) 77.1 (69.1–83.5) 67.9 (55.1–78.8) !.0001
Male sex 526 (58.6) 37 (52.9) 489 (59.1) .31
Length of stay, median (IQR), days 8 (4–13) 12 (8.75–17.0) 8 (4–13) !.0001
Mean daily nursing workload index, median (IQR) 33.3 (25.5–44.2)a 37.4 (29.0–51.7)b 32.8 (25.2–43.5)c .003
MSSA carriage at admission 192 (21.4) 14 (20.0) 178 (21.5) .77
MSSA carriage at discharge 113 (12.6) 6 (8.6) 107 (12.9) .29
Comorbidities
Congestive heart failure 127 (14.1) 15 (21.4) 112 (13.5) .07
Dementia 20 (2.2) 2 (2.9) 18 (2.2) .66
Chronic pulmonary disease 118 (13.1) 16 (22.9) 102 (12.3) .01
Rheumatic disease 18 (2.0) 1 (1.4) 17 (2.1) 1.0
Mild liver disease 2 (0.2) 0 2 (0.2) 1.0
Diabetes with chronic complication 42 (4.7) 1 (1.4) 41 (5.0) .24
Renal disease 74 (8.2) 10 (14.3) 64 (7.7) .055
Any malignancyd 168 (18.7) 10 (14.3) 158 (19.1) .32
Moderate or severe liver disease 17 (1.9) 0 17 (2.1) .64
Metastatic solid tumor 73 (8.1) 4 (5.7) 69 (8.3) .44
AIDS/HIV 6 (0.7) 1 (1.4) 5 (0.6) .39
Charlson comorbidity index, median (IQR) 4 (3–6) 5 (4–7) 4 (3–6) .005
Antibiotic usee 183 (20.4) 17 (24.3) 166 (20.0) .40
Penicillin 63 (7.0) 5 (7.1) 58 (7.0) 1.0
Aminoglycoside 7 (0.8) 0 7 (0.8) 1.0
Macrolide 22 (2.4) 7 (10.0) 15 (1.8) .001
Cephalosporin 37 (4.1) 3 (4.3) 34 (4.1) .76
Fluoroquinolone 44 (4.9) 6 (8.6) 38 (4.6) .14
Clindamycin 2 (0.2) 0 2 (0.2) 1.0
Anti-tuberculosis treatment 3 (0.3) 0 3 (0.4) 1.0
Carbapenem 13 (1.4) 2 (2.9) 11 (1.3) .27
Metronidazole 6 (0.7) 1 (1.4) 5 (0.6) .39
Anti-MRSA antibioticsf 22 (2.4) 2 (2.9) 20 (2.4) .69
note. Data are no. (%) of patients, unless otherwise indicated. Boldface type indicates statistical significance. AIDS, acquired
immunodeficiency syndrome; HIV, human immunodeficiency virus; IQR, interquartile range; MSSA, methicillin-susceptible
S. aureus.
a n p 762.
b n p 62.
c n p 700.
d Any malignancy, including lymphoma and leukemia, except malignant neoplasm of skin.
e Assessed during stay and defined as the administration of antibiotics at least 1 day before the final negative or positive
surveillance or clinical culture for MRSA.
f Anti-MRSA antibiotics include doxycycline, co-trimoxazole, rifampin, vancomycin, and teicoplanin.
discussion
Our results do not confirm the hypothesis that MSSA col-
onization protects against nosocomial MRSA acquisition in
a population of medical patients without strong antibiotic
selection pressure. By contrast, our findings confirm well-
known risk factors for nosocomial MRSA acquisition such as
age, LOS, nursing workload, and previous treatment with
macrolides.
There is historical evidence that colonization with a specific
S. aureus strain prevents exogenous colonization with other
strains. Bacterial interference by active colonization using a
nonpathogenic S. aureus strain (502A) was successful in child
nurseries during staphylococcal outbreaks in the 1960s and
for the treatment of patients with recurrent furunculosis.26,27
More recently, Dall’Antonia et al16 tested the hypothesis that
MRSA strains compete with MSSA for colonization of the
anterior nares. Using a cross-sectional approach in 3 UK
hospitals, the authors found a lower prevalence of co-carriers
than expected and estimated a protective effect of MSSA col-
onization of 78% for the prevention of MRSA carriage.
The association between endogenous MSSA carriage and
its potential protective effect against nosocomial MRSA ac-
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quisition has not been extensively studied. The few published
studies have shown contradictory results.17,18 For instance,
Krebes et al18 showed that noncarriers of MSSA were not
more susceptible to acquiring MRSA compared with MSSA
carriers. Among 840 included patients, 9 (21.4%) of 42 pa-
tients who acquired MRSA during their hospitalization versus
178 (23%) of 775 patients who did not acquire MRSA were
MSSA carriers. These results and our findings stand in con-
trast to a recent US study that suggests that MSSA carriage
may reduce the odds of MRSA acquisition by 50% in intensive
care units.17 This discrepancy may be explained by differences
in case mix, patient host factors, intensity of contact with
healthcare personnel, and frequency and type of antibiotic
exposure.
Consistent with earlier reports on MRSA acquisition, we
found that patients who acquired nosocomial MRSA were
older,28 had longer LOS,15,17,29,30 and more frequent exposure
to macrolides.31 Interestingly, we found no statistical associ-
ation with fluoroquinolones and cephalosporins,13,14,17,32 but
this is possibly related to a lack of power due to the low
number of patients exposed to these antibiotics in our pop-
ulation. We also observed that higher nursing workload was
a risk factor of nosocomial MRSA acquisition. Several studies
have linked overcrowding, understaffing, or nursing workload
with cross-transmission of MRSA, Enterobacteriaceae, or gas-
trointestinal viruses.33,34
Regarding MSSA, we observed that 56% of MSSA carriers
at admission became MSSA negative after hospital stay. The
observed disappearance of MSSA at discharge from the di-
vision may be explained by (1) possible intermittent MSSA
carriage;2,35 (2) the previous exposure to antibiotics,35 because
most commonly used antibiotics have activity again MSSA;
and (3) the effect of other in-hospital interventions not as-
sessed in our study (eg, body cleaning with antiseptic soaps).
A total of 4% of patients free of MSSA carriage at admission
became MSSA positive, and 8% of patients free of MRSA
carriage at admission became MRSA positive. We cannot at-
tribute the 4% of MSSA positivity at discharge to a noso-
comial acquisition. Transient MSSA carriage has been well
described in the medical literature,2,35 but this is not the case
for healthcare-associated MRSA carriage among patients.
Moreover, in our community, we have very limited com-
munity-associated MRSA carriage; incidence was 4 cases per
100,000 inhabitants in 2007.36 These factors decrease the like-
lihood of intermittent MRSA carriage compared with the
phenomenon frequently observed for MSSA.
Among the 70 cases with nosocomial MRSA acquisition,
none of the 56 MSSA-free patients at admission became
MSSA positive. We did not record simultaneous, nosocomial
co-acquisition of both MRSA and MSSA. This could be ex-
plained by currently used microbiology methods, which make
it difficult to detect low-level carriage of MSSA in the presence
of heavy MRSA colonization.37 Furthermore, there may be
competition between MSSA and MRSA during hospital stay
among patients initially free of any S. aureus carriage. For
instance, Dall’Antonia et al16 found 4 patients (0.6%) among
680 who carried both MRSA and MSSA. Nosocomial acqui-
sition of both MSSA and MRSA is possible but seems to be
a very rare event.
Our study has limitations. First, a relatively high propor-
tion of patients was missed at admission or discharge screen-
ing, as previously reported.19 Nevertheless, the included pa-
tient population was diverse and is probably representative
of the population encountered in other medical units. Fur-
thermore, it is unlikely that a higher recruitment would have
substantially modified the main effect estimate. Second, we
were not able to adjust our model for colonization pressure.
However, in a recent review by Ajao et al38 that included 8
studies of risk factors for MRSA acquisition, only 3 found
colonization pressure to be significantly associated with ac-
quisition. Third, we cannot exclude that admission screening
could have been insufficiently sensitive as a result of a low
bacterial burden at sampled sites or incorrect sampling. How-
ever, we are confident that we have captured the majority of
carriage by screening an additional body site (groin) in con-
trast to most previous studies cited above. Groin swab was
chosen to detect patients with gastrointestinal MRSA car-
riage39 and to increase the yield of nasal screening only.40 We
have previously determined at our institution that the ad-
dition of throat screening did not significantly improve the
accuracy of detecting MRSA colonization.41 Fourth, swabs
were pooled before inoculation to decrease the cost of anal-
yses. Therefore, acquisition rates by body site could not be
calculated. Finally, this study was conducted among internal
medicine patients at a single institution, and our findings
might not be generalizable to other settings.
In conclusion, our study presents a new perspective on the
interaction between endogenous MSSA colonization and nos-
ocomial MRSA acquisition and provides a strong quantitative
basis on this subject. Additional research is necessary to in-
vestigate whether MSSA colonization in patient populations
with a different case-mix and antibiotic exposure patterns
may have a different protective effect.
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